ARTICLE | Clinical News
DC Bead regulatory update
September 1, 2014 7:00 AM UTC
BTG and partner SciClone Pharmaceuticals Inc. (NASDAQ:SCLN, Foster City, Calif.) said the China Food and Drug Administration (CFDA) approved BTG's DC Bead to treat patients with malignant hypervascul...